Themes US R&D Champions ETF
USRD
1 hedge funds and large institutions have $1.23K invested in Themes US R&D Champions ETF in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
4.32% less ownership
Funds ownership: 4.44% → 0.13% (-4.3%)
50% less funds holding
Funds holding: 2 → 1 (-1)
97% less capital invested
Capital invested by funds: $36.8K → $1.23K (-$35.6K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$145 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$35.9K |
USRD Hedge Fund Activity: Q2 2025 in Review
1 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Themes US R&D Champions ETF (USRD) for Q2 2025, worth a combined $1.23K — down 97% from $36.8K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of USRD and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $145. The largest seller was Geneos Wealth Management, exiting entirely with an estimated $35.9K sold.
- 1 institutional investor held Themes US R&D Champions ETF (USRD) as of Q2 2025, down from 2 in Q1 2025.
- Funds reported $1.23K of Themes US R&D Champions ETF stock for Q2 2025, down 97% quarter-over-quarter.
- 0 funds opened new Themes US R&D Champions ETF positions in Q2 2025 and 1 closed out, a net change of -1 holder.
- The largest Themes US R&D Champions ETF buyer in Q2 2025 was UBS Group, an estimated $145 added.
- The largest Themes US R&D Champions ETF seller in Q2 2025 was Geneos Wealth Management, an estimated $35.9K sold.
Based on aggregated 13F filings for Q2 2025.